Dyadic(DYAI) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress JUPITER, Fla., May 14, 2025 — Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary production strains to manufacture large quantities of precision-engineered proteins and enzymes for use in life science, nutrition, and industrial applications, today announced ...